SEARCH

SEARCH BY CITATION

References

  • 1
    Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 19531971.
  • 2
    Panitch, H. S., Hirsch, R. L., Haley, A. S. and Johnson, K. P., Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987. 1: 893895.
  • 3
    Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R. and Steinman, L., T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985. 317: 355358.
  • 4
    Renno, T., Taupin, V., Bourbonniere, L., Verge, G., Tran, E., De Simone, R., Krakowski, M. et al., Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 1998. 12: 376389.
  • 5
    Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. et al., Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 57.
  • 6
    Becher, B., Durell, B. G. and Noelle, R. J., Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 2002. 110: 493497.
  • 7
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 8
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 9
    Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P., Van Kaer, L. and Miller, S. D., De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2002. 168: 41734183.
  • 10
    Hickey, W. F. and Kimura, H., Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988. 239: 290292.
  • 11
    Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J. et al., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005. 11: 328334.
  • 12
    McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. and Miller, S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005. 11: 335339.
  • 13
    Bailey, S. L., Schreiner, B., McMahon, E. J. and Miller, S. D., CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4(+) T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007. 8: 172180.
  • 14
    McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C. and Miller, S. D., Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995. 182: 7585.
  • 15
    Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C. and Bluestone, J. A., Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995. 3: 739745.
  • 16
    Vanderlugt, C. L., Eagar, T. N., Neville, K. L., Nikcevich, K. M., Bluestone, J. A. and Miller, S. D., Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 2000. 164: 670678.
  • 17
    Howard, L. M., Miga, A. J., Vanderlugt, C. L., Dal Canto, M. C., Laman, J. D., Noelle, R. J. and Miller, S. D., Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 1999. 103: 281290.
  • 18
    Karandikar, N. J., Eagar, T. N., Vanderlugt, C. L., Bluestone, J. A. and Miller, S. D., CTLA-4 downregulates epitope spreading and mediates remission in autoimmune disease. J. Neuroimmunol. 2000. 109: 173180.
  • 19
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 10271034.
  • 20
    Dong, H., Zhu, G., Tamada, K. and Chen, L., B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 1999. 5: 13651369.
  • 21
    Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T. et al., Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002. 169: 55385545.
  • 22
    Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. et al., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 12571266.
  • 23
    Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M. and Galli, S. J., Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 2006. 176: 22382248.
  • 24
    Rodig, N., Ryan, T., Allen, J. A., Pang, H., Grabie, N., Chernova, T., Greenfield, E. A. et al., Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 2003. 33: 31173126.
  • 25
    Petroff, M. G., Chen, L., Phillips, T. A., Azzola, D., Sedlmayr, P. and Hunt, J. S., B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 2003. 68: 14961504.
  • 26
    Schoop, R., Wahl, P., Le Hir, M., Heemann, U., Wang, M. and Wuthrich, R. P., Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol. Dial. Transplant. 2004. 19: 27132720.
  • 27
    Nakazawa, A., Dotan, I., Brimnes, J., Allez, M., Shao, L., Tsushima, F., Azuma, M. et al., The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 2004. 126: 13471357.
  • 28
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y. et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 29
    Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A. et al., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001. 193: 839846.
  • 30
    Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H. and Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996. 8: 765772.
  • 31
    Ishida, M., Iwai, Y., Tanaka, Y., Okazaki, T., Freeman, G. J., Minato, N. and Honj, T., Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett. 2002. 84: 5762.
  • 32
    Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239245.
  • 33
    Pentcheva-Hoang, T., Chen, L., Pardoll, D. M. and Allison, J. P., Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc. Natl. Acad. Sci. USA 2007. 104: 1776517770.
  • 34
    Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141151.
  • 35
    Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S. et al., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319322.
  • 36
    Lin, S. C., Yen, J. H., Tsai, J. J., Tsai, W. C., Ou, T. T., Liu, H. W. and Chen, C. J., Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 2004. 50: 770775.
  • 37
    Ansari, M. J., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T. et al., The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 2003. 198: 6369.
  • 38
    Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M. et al., Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2003. 198: 7178.
  • 39
    Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S. et al., PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 182: 124134.
  • 40
    Shin, T., Kennedy, G., Gorski, K., Tsuchiya, H., Koseki, H., Azuma, M., Yagita, H. et al., Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 2003. 198: 3138.
  • 41
    Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H. et al., In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J. Exp. Med. 2005. 201: 15311541.
  • 42
    Yamazaki, T., Akiba, H., Koyanagi, A., Azuma, M., Yagita, H. and Okumura, K., Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J. Immunol. 2005. 175: 15861592.
  • 43
    Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T. and Chen, L., Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 2003. 197: 10831091.
  • 44
    Liu, X., Gao, J. X., Wen, J., Yin, L., Li, O., Zuo, T., Gajewski, T. F. et al., B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp Med. 2003. 197: 17211730.
  • 45
    Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H. and Freeman, G. J., Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007. 27: 111122.
  • 46
    Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883895.
  • 47
    Fife, B. T., Guleria, I., Gubbels Bupp, M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H. et al., Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 2006. 203: 27372747.
  • 48
    Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y. et al., Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 2004. 113: 694700.
  • 49
    Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K. et al., PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 1069110696.
  • 50
    Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., Yagita, H. et al., Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 34803489.
  • 51
    Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J. and Sharpe, A. H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003. 33: 27062716.
  • 52
    Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., Ifergan, I. et al., Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 2005. 25: 25372546.
  • 53
    Ortler, S., Leder, C., Mittelbronn, M., Zozulya, A. L., Knolle, P. A., Chen, L., Kroner, A. et al., B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 2008. 38: 17341744.
  • 54
    Goldberg, M. V., Maris, C. H., Hipkiss, E. L., Flies, A. S., Zhen, L., Tuder, R. M., Grosso, J. F. et al., Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8T cells. Blood 2007. 110: 186192.
  • 55
    Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K. and Armitage, R. J., Human IL-17: a novel cytokine derived from T cells. J. Immunol. 1995. 155: 54835486.
  • 56
    Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J. et al., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996. 183: 25932603.
  • 57
    Saudemont, A., Jouy, N., Hetuin, D. and Quesnel, B., NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005. 105: 24282435.
  • 58
    Huang, D., Shi, F. D., Jung, S., Pien, G. C., Wang, J., Salazar-Mather, T. P., He, T. T. et al., The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006. 20: 896905.
  • 59
    Juedes, A. E. and Ruddle, N. H., Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 2001. 166: 51685175.
  • 60
    Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J. et al., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006. 439: 682687.
  • 61
    Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T. and Honjo, T., PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 2003. 198: 3950.
  • 62
    Matsumoto, K., Inoue, H., Nakano, T., Tsuda, M., Yoshiura, Y., Fukuyama, S., Tsushima, F. et al., B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J. Immunol. 2004. 172: 25302541.
  • 63
    Hirata, S., Senju, S., Matsuyoshi, H., Fukuma, D., Uemura, Y. and Nishimura, Y., Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. J. Immunol. 2005. 174: 18881897.
  • 64
    Waldner, H., Whitters, M. J., Sobel, R. A., Collins, M. and Kuchroo, V. K., Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. USA 2000. 97: 34123417.
  • 65
    Dong, H., Zhu, G., Tamada, K., Flies, D. B., van Deursen, J. M. and Chen, L., B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 2004. 20: 327336.
  • 66
    Turley, D. M. and Miller, S. D., Peripheral tolerance Induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 22122220.
  • 67
    Katz-Levy, Y., Neville, K. L., Padilla, J., Rahbe, S. M., Begolka, W. S., Girvin, A. M., Olson, J. K. et al., Temporal development of autoreactive Th1 responses and endogenous antigen presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J. Immunol. 2000. 165: 53045314.